Endosomal TLRs and their accessory proteins: cell biology and biochemistry
Endosomal TLRs and their accessory proteins: cell biology and biochemistry
批准号:
8250504
负责人:
Hidde L. Ploegh
金额:
$37.05万
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-04-10 至 2016-01-31
关键词:
AddressAnimal ModelAnimalsAntibodiesAntibody FormationAntigen PresentationAntigen-Presenting CellsAntigensAutoimmunityB-Cell ActivationB-LymphocytesBehaviorBiochemicalBiochemistryBiologicalBiologyCell LineCell NucleusCell physiologyCell surfaceCellsCellular biologyCherry - dietaryChimeric ProteinsClostridium perfringens theta-toxinComplementConfocal MicroscopyDifferentiation AntigensElementsEpitopesGenerationsGenetic ScreeningHaploidyHost DefenseIgG1Immune responseImmune systemImmunityImmunoglobulin Class SwitchingImmunoglobulin Switch RecombinationKnowledgeLabelLaboratory StudyLifeLigand BindingLigandsMetabolicModelingMolecularMusNucleic AcidsOvalbuminPathway interactionsPatternProcessProductionPropertyProteinsReceptor ActivationReceptor SignalingReceptors, Antigen, B-CellRefractoryResearchRoleSignal TransductionSiteSourceSpecificitySystemT cell responseT-LymphocyteTLR3 geneTLR7 geneTechniquesToll-like receptorsTransfectionTransgenesTransgenic AnimalsTransgenic MiceViralbasecell typecellular imagingcofactorcytokinedesignhuman TLR7 proteinimprovedmacrophagemicrobialmouse modelnovelpathogenphagocytosis receptorprogramsreceptorreceptor mediated endocytosisresearch studyresponsesomatic cell nuclear transfertooltraffickingvaccine efficacy
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): A detailed understanding of the trafficking behavior of the endosomal TLRs, as exemplified by that of TLR9, should aid in the design of strategies that improve delivery of antigen to processing compartments in professional antigen presenting cells, concomitant with appropriate activation of the antigen presenting cell. Consequently, this knowledge is expected to contribute to an understanding of the efficacy of vaccines currently in use, and how to improve on them. B cells represent a special target in this regard, as they not only capture antigen via a signaling receptor, the B cell receptor for antigen, which then activates the B cell, but they also possess TLRs whose engagement contributes to B cell activation per se. Other antigen presenting cells that require engagement of TLRs for full activation, production of cytokines and display of costimulatory molecules capture antigen by other means, including phagocytosis and receptor mediated endocytosis, using signaling apparatus distinct form that available to B cells. Cell-autonomous and cell type-specific factors that control endosomal TLR trafficking and function are therefore likely to be important. To address these questions, new animal models have been generated. These include a TLR9-GFP transgenic mouse, to be complemented by a TLR7-GFP mouse, and a transnuclear (TN) mouse model made by somatic cell nuclear transfer, using the nucleus of an ovalbumin-specific B cell as nucleus donor; the resulting mice possess B cells that produce ovalbumin-specific IgG1. Having established an important role for Unc93B1 in escorting functional endosomal TLRs to their site of action, much of the biochemical and cell biological details that underlie Unc93B1s function remain to be determined. The differential requirements displayed by TLR7 and TLR9 for distinct structural elements within Unc93B1 require a molecular explanation. Combined, the results of the proposed experiments, performed with altogether new mouse models, should illuminate the cell biology and function of a class of TLRs of known importance to host defense and implicated in autoimmunity. A combination of live cell imaging, biochemistry and functional readouts (cytokine production, expression of activation markers, antigen presentation) will be applied to the following aims: Aim 1: The TLR-GFP animal models will be applied to study endosomal Toll-like receptor 7 and 9 (TLR7/9) ligand binding, trafficking and proteolytic cleavage, to identify novel TLR7/9 cofactors required for trafficking, signaling and/or cleavage and to identify new players in TLR7/9 signaling. Aim 2: The TLR-GFP mice will be combined with the ovalbumin-specific TN mice to analyze the synergy between TLR and BCR signaling in B cell activation in response to a combination of BCR and TLR ligands. Aim 3: The molecular determinants of UNC93B1 required for trafficking, interaction and activation of TLRs will be examined, making use of new chemoenzymatic tools to study its topology and interacting partners.
PUBLIC HEALTH RELEVANCE: Project narrative. New animal models are proposed to study the trafficking properties and interacting proteins of the endosomal TLRs (TLR7 and TLR9) and their essential partner, Unc93B1, through construction of animals transgenic for GFP-tagged TLRs. These models will be combined with transnuclear mice, created by somatic cell nuclear transfer to yield animals with ovalbumin-specific B cells, to study the interplay between TLR- and BCR derived signals for proper B cell activation, using live cell imaging and biochemistry.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Imposing order on the family of ubiquitin-conjugating (E2) enzymes through intracellular perturbation with nanobodies
-
批准号:10464850
-
项目类别:
-
资助金额:$44.25万
-
财政年份:2021
-
负责人:Hidde L. Ploegh
-
依托单位:
Non-invasive imaging of the anti-tumor immune response
-
批准号:10520018
-
项目类别:
-
资助金额:$57.59万
-
财政年份:2020
-
负责人:Hidde L. Ploegh
-
依托单位:
Non-invasive imaging of the anti-tumor immune response
-
批准号:10318578
-
项目类别:
-
资助金额:$57.59万
-
财政年份:2020
-
负责人:Hidde L. Ploegh
-
依托单位:
Imposing order on the family of ubiquitin-conjugating (E2) enzymes through intracellular perturbation with nanobodies
-
批准号:10461021
-
项目类别:
-
资助金额:$123.9万
-
财政年份:2019
-
负责人:Hidde L. Ploegh
-
依托单位:
Imposing order on the family of ubiquitin-conjugating (E2) enzymes through intracellular perturbation with nanobodies
-
批准号:10208670
-
项目类别:
-
资助金额:$123.9万
-
财政年份:2019
-
负责人:Hidde L. Ploegh
-
依托单位:
Imposing order on the family of ubiquitin-conjugating (E2) enzymes through intracellular perturbation with nanobodies
-
批准号:10671648
-
项目类别:
-
资助金额:$123.9万
-
财政年份:2019
-
负责人:Hidde L. Ploegh
-
依托单位:
Imposing order on the family of ubiquitin-conjugating (E2) enzymes through intracellular perturbation with nanobodies
-
批准号:10002176
-
项目类别:
-
资助金额:$123.9万
-
财政年份:2019
-
负责人:Hidde L. Ploegh
-
依托单位:
Non-invasive imaging of the immune response based on the use of isotopically labeled single domain antibody fragments
-
批准号:8873207
-
项目类别:
-
资助金额:$29.25万
-
财政年份:2015
-
负责人:Hidde L. Ploegh
-
依托单位:
Sortase-mediated installation of recognition modules on T cells for redirected ki
-
批准号:8683479
-
项目类别:
-
资助金额:$25.45万
-
财政年份:2014
-
负责人:Hidde L. Ploegh
-
依托单位:
Endosomal TLRs and their accessory proteins: cell biology and biochemistry
-
批准号:8454409
-
项目类别:
-
资助金额:$35.75万
-
财政年份:2012
-
负责人:Hidde L. Ploegh
-
依托单位:
Enzymatic modification of anti-DEC205 to manipulate its immunogenic properties
-
批准号:8386128
-
项目类别:
-
资助金额:$29.25万
-
财政年份:2012
-
负责人:Hidde L. Ploegh
-
依托单位:
A new strategy to disrupt protein-protein interactions in eukaryotic cells.
-
批准号:8550122
-
项目类别:
-
资助金额:$94.58万
-
财政年份:2012
-
负责人:Hidde L. Ploegh
-
依托单位:
A new strategy to disrupt protein-protein interactions in eukaryotic cells.
-
批准号:9381676
-
项目类别:
-
资助金额:$59.3万
-
财政年份:2012
-
负责人:Hidde L. Ploegh
-
依托单位:
A new strategy to disrupt protein-protein interactions in eukaryotic cells.
-
批准号:8351788
-
项目类别:
-
资助金额:$97.5万
-
财政年份:2012
-
负责人:Hidde L. Ploegh
-
依托单位:
Enzymatic modification of anti-DEC205 to manipulate its immunogenic properties
-
批准号:8518230
-
项目类别:
-
资助金额:$22.91万
-
财政年份:2012
-
负责人:Hidde L. Ploegh
-
依托单位:
A new strategy to disrupt protein-protein interactions in eukaryotic cells.
-
批准号:8900317
-
项目类别:
-
资助金额:$97.5万
-
财政年份:2012
-
负责人:Hidde L. Ploegh
-
依托单位:
A new strategy to disrupt protein-protein interactions in eukaryotic cells.
-
批准号:9117623
-
项目类别:
-
资助金额:$32.18万
-
财政年份:2012
-
负责人:Hidde L. Ploegh
-
依托单位:
A new strategy to disrupt protein-protein interactions in eukaryotic cells.
-
批准号:8710286
-
项目类别:
-
资助金额:$97.5万
-
财政年份:2012
-
负责人:Hidde L. Ploegh
-
依托单位:
UBIQUITIN C-TERMINAL HYDROLASE L3 COMPLEX WITH UBIQUITIN-BASED SUICIDE SUBSTRATE
-
批准号:8361612
-
项目类别:
-
资助金额:$0.33万
-
财政年份:2011
-
负责人:Hidde L. Ploegh
-
依托单位:
Sortase-mediated protein engineering for the study of host-pathogen interactions
-
批准号:8431398
-
项目类别:
-
资助金额:$45.37万
-
财政年份:2010
-
负责人:Hidde L. Ploegh
-
依托单位:
海外基金